{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:23:58Z","timestamp":1793683438279,"version":"4.5.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was to evaluate the short-term effect of HFNT versus NIV in patients with mild-to-moderate AECOPD, with the hypothesis that HFNT is non-inferior to NIV on CO\n                      <jats:sub>2<\/jats:sub>\n                      clearance after 2\u00a0h of treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a multicenter, non-inferiority randomized trial comparing HFNT and noninvasive ventilation (NIV) in nine centers in Italy. Patients were eligible if presented with mild-to-moderate AECOPD (arterial pH 7.25\u20137.35, PaCO\n                      <jats:sub>2<\/jats:sub>\n                      \u2009\u2265\u200955\u00a0mmHg before ventilator support). Primary endpoint was the mean difference of PaCO\n                      <jats:sub>2<\/jats:sub>\n                      from baseline to 2\u00a0h (non-inferiority margin 10\u00a0mmHg) in the per-protocol analysis. Main secondary endpoints were non-inferiority of HFNT to NIV in reducing PaCO\n                      <jats:sub>2<\/jats:sub>\n                      at 6\u00a0h in the per-protocol and intention-to-treat analysis and rate of treatment changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-nine patients were analyzed (80 patients randomized). Mean differences for PaCO\n                      <jats:sub>2<\/jats:sub>\n                      reduction from baseline to 2\u00a0h were \u2212 6.8\u00a0mmHg (\u00b1\u20098.7) in the HFNT and \u2212 9.5\u00a0mmHg (\u00b1\u20098.5) in the NIV group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.404). By 6\u00a0h, 32% of patients (13 out of 40) in the HFNT group switched to NIV and one to invasive ventilation. HFNT was statistically non-inferior to NIV since the 95% confidence interval (CI) upper boundary of absolute difference in mean PaCO\n                      <jats:sub>2<\/jats:sub>\n                      reduction did not reach the non-inferiority margin of 10\u00a0mmHg (absolute difference 2.7\u00a0mmHg; 1-sided 95% CI 6.1;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003). Both treatments had a significant effect on PaCO\n                      <jats:sub>2<\/jats:sub>\n                      reductions over time, and trends were similar between groups. Similar results were found in both per-protocol at 6\u00a0h and intention-to-treat analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      HFNT was statistically non-inferior to NIV as initial ventilatory support in decreasing PaCO\n                      <jats:sub>2<\/jats:sub>\n                      after 2\u00a0h of treatment in patients with mild-to-moderate AECOPD, considering a non-inferiority margin of 10\u00a0mmHg. However, 32% of patients receiving HFNT required NIV by 6\u00a0h. Further trials with superiority design should evaluate efficacy toward stronger patient-related outcomes and safety of HFNT in AECOPD.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : The study was prospectively registered on December 12, 2017, in ClinicalTrials.gov (NCT03370666).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-020-03409-0","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:04:45Z","timestamp":1607925885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial"],"prefix":"10.1186","volume":"24","author":[{"name":"the H. F.-AECOPD study investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-9993","authenticated-orcid":false,"given":"Andrea","family":"Cortegiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Longhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Madotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Groff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Crimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santi Maurizio","family":"Raineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Comellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Vetrugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Clini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Navalesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Gregoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"3409_CR1","first-page":"53","volume":"2019","author":"D Singh","year":"2019","unstructured":"Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J Engl. 2019;2019:53.","journal-title":"Eur Respir J Engl"},{"key":"3409_CR2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1183\/09031936.00109906","volume":"29","author":"BR Celli","year":"2007","unstructured":"Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J Engl. 2007;29:1224\u201338.","journal-title":"Eur Respir J Engl"},{"key":"3409_CR3","doi-asserted-by":"publisher","first-page":"1602426","DOI":"10.1183\/13993003.02426-2016","volume":"50","author":"B Rochwerg","year":"2017","unstructured":"Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50:1602426.","journal-title":"Eur Respir J"},{"key":"3409_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccc.2015.03.002","volume":"31","author":"C Gregoretti","year":"2015","unstructured":"Gregoretti C, Pisani L, Cortegiani A, Ranieri VM. Noninvasive ventilation in critically ill patients. Crit Care Clin US. 2015;31:435\u201357.","journal-title":"Crit Care Clin US"},{"key":"3409_CR5","first-page":"676","volume":"85","author":"A Bruni","year":"2019","unstructured":"Bruni A, Garofalo E, Pelaia C, Messina A, Cammarota G, Murabito P, et al. Patient-ventilator asynchrony in adult critically ill patients. Minerva Anestesiol Italy. 2019;85:676\u201388.","journal-title":"Minerva Anestesiol Italy"},{"key":"3409_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12871-017-0409-0","volume":"17","author":"A Cortegiani","year":"2017","unstructured":"Cortegiani A, Russotto V, Antonelli M, Azoulay E, Carlucci A, Conti G, et al. Ten important articles on noninvasive ventilation in critically ill patients and insights for the future: a report of expert opinions. BMC Anesthesiol. 2017;17:122.","journal-title":"BMC Anesthesiol"},{"key":"3409_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/17476348.2018.1480941","volume":"12","author":"E Garofalo","year":"2018","unstructured":"Garofalo E, Bruni A, Pelaia C, Liparota L, Lombardo N, Longhini F, et al. Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. Expert Rev Respir Med Engl. 2018;12:557\u201367.","journal-title":"Expert Rev Respir Med Engl"},{"key":"3409_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tacc.2019.02.001","volume":"26\u201327","author":"G Spoletini","year":"2019","unstructured":"Spoletini G, Cortegiani A, Gregoretti C. Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: a narrative review. Trends Anaesth Crit Care. 2019;26\u201327:22\u20139.","journal-title":"Trends Anaesth Crit Care"},{"key":"3409_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.aucc.2007.08.001","volume":"20","author":"N Groves","year":"2007","unstructured":"Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20:126\u201331.","journal-title":"Aust Crit Care"},{"key":"3409_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06228-7","author":"JD Ricard","year":"2020","unstructured":"Ricard JD, Roca O, Lemiale V, Corley A, Braunlich J, Jones P, et al. Use of nasal high flow oxygen during acute respiratory failure. Intensive Care Med. 2020. https:\/\/doi.org\/10.1007\/s00134-020-06228-7.","journal-title":"Intensive Care Med"},{"key":"3409_CR11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1183\/09031936.97.10102250","volume":"10","author":"P Fontanari","year":"1997","unstructured":"Fontanari P, Zattara-Hartmann MC, Burnet H, Jammes Y. Nasal eupnoeic inhalation of cold, dry air increases airway resistance in asthmatic patients. Eur Respir J. 1997;10:2250\u20134.","journal-title":"Eur Respir J"},{"key":"3409_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1164\/ajrccm.163.6.2002129","volume":"163","author":"LS On","year":"2001","unstructured":"On LS, Boonyongsunchai P, Webb S, Davies L, Calverley PMA, Costello RW. Function of pulmonary neuronal M2 muscarinic receptors in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1320\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"3409_CR13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00134-004-2235-3","volume":"30","author":"E Kilgour","year":"2004","unstructured":"Kilgour E, Rankin N, Ryan S, Pack R. Mucociliary function deteriorates in the clinical range of inspired air temperature and humidity. Intensive Care Med. 2004;30:1491\u20134.","journal-title":"Intensive Care Med"},{"key":"3409_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/15412555.2020.1728736","volume":"17","author":"C Crimi","year":"2020","unstructured":"Crimi C, Noto A, Cortegiani A, Campisi R, Heffler E, Gregoretti C, et al. High flow nasal therapy use in patients with acute exacerbation of COPD and bronchiectasis: a feasibility study. COPD J Chronic Obstr Pulm Dis. 2020;17:184\u201390.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"3409_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/thoraxjnl-2016-209673","volume":"72","author":"L Pisani","year":"2017","unstructured":"Pisani L, Fasano L, Corcione N, Comellini V, Musti MA, Brandao M, et al. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax. 2017;72:373\u20135.","journal-title":"Thorax"},{"key":"3409_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.pulmoe.2019.08.001","volume":"25","author":"L Pisani","year":"2019","unstructured":"Pisani L, Astuto M, Prediletto I, Longhini F. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology. 2019;25:348\u201354.","journal-title":"Pulmonology"},{"key":"3409_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/resp.13050","volume":"22","author":"J Pilcher","year":"2017","unstructured":"Pilcher J, Eastlake L, Richards M, Power S, Cripps T, Bibby S, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology. 2017;22:1149\u201355.","journal-title":"Respirology"},{"key":"3409_CR18","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.2147\/COPD.S185001","volume":"13","author":"J Br\u00e4unlich","year":"2018","unstructured":"Br\u00e4unlich J, Wirtz H. Nasal high-flow in acute hypercapnic exacerbation of COPD. Int J COPD. 2018;13:3995\u20133897.","journal-title":"Int J COPD"},{"key":"3409_CR19","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1097\/CCM.0000000000003740","volume":"47","author":"F Longhini","year":"2019","unstructured":"Longhini F, Pisani L, Lungu R, Comellini V, Bruni A, Garofalo E, et al. High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med. 2019;47:e506\u201311.","journal-title":"Crit Care Med"},{"key":"3409_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13613-019-0597-5","volume":"9","author":"N Rittayamai","year":"2019","unstructured":"Rittayamai N, Phuangchoei P, Tscheikuna J, Praphruetkit N, Brochard L. Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study. Ann Intensive Care. 2019;9:122.","journal-title":"Ann Intensive Care"},{"key":"3409_CR21","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/crj.12772","volume":"12","author":"MK Lee","year":"2018","unstructured":"Lee MK, Choi J, Park B, Kim B, Lee SJ, Kim SH, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J. 2018;12:2046\u201356.","journal-title":"Clin Respir J"},{"key":"3409_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/COPD.S206567","volume":"14","author":"J Sun","year":"2019","unstructured":"Sun J, Li Y, Ling B, Zhu Q, Hu Y, Tan D, et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J COPD. 2019;14:1229\u201339.","journal-title":"Int J COPD"},{"key":"3409_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15412555.2020.1715361","volume":"7","author":"I Pantazopoulos","year":"2020","unstructured":"Pantazopoulos I, Daniil Z, Moylan M, Gourgoulianis K, Chalkias A, Zakynthinos S, et al. Nasal high flow use in COPD patients with hypercapnic respiratory failure: treatment algorithm & review of the literature. COPD J Chronic Obstr Pulm Dis. 2020;7:101\u201311.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"3409_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13063-019-3514-1","volume":"20","author":"A Cortegiani","year":"2019","unstructured":"Cortegiani A, Longhini F, Carlucci A, Scala R, Groff P, Bruni A, et al. High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials. 2019;20:450.","journal-title":"Trials"},{"key":"3409_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med. 2017;195:557\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"3409_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1183\/09031936.00053814","volume":"45","author":"L Pisani","year":"2015","unstructured":"Pisani L, Mega C, Vaschetto R, Bellone A, Scala R, Cosentini R, et al. Oronasal mask versus helmet in acute hypercapnic respiratory failure. Eur Respir J. 2015;45:691\u20139.","journal-title":"Eur Respir J"},{"key":"3409_CR27","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1378\/chest.104.6.1818","volume":"104","author":"BJ Kelly","year":"1993","unstructured":"Kelly BJ, Matthay MA. Prevalence and severity of neurologic dysfunction in critically ill patients: Influence on need for continued mechanical ventilation. Chest. 1993;104:1818\u201324.","journal-title":"Chest"},{"key":"3409_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"3409_CR29","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O\u2019Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166:1338\u201344.","journal-title":"Am J Respir Crit Care Med"},{"key":"3409_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0099-1767(00)90093-X","volume":"26","author":"KR Kendrick","year":"2000","unstructured":"Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0\u201310 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26:216\u201322.","journal-title":"J Emerg Nurs"},{"key":"3409_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201402-0364OC","volume":"190","author":"SM Maggiore","year":"2014","unstructured":"Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus venturi mask oxygen therapy after extubation: effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190:282\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"3409_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/resp.13092","volume":"22","author":"J Br\u00e4unlich","year":"2017","unstructured":"Br\u00e4unlich J, Wirtz H. NHF and hypercapnia: how brief can you look? Respirology. 2017;22:1049\u201350.","journal-title":"Respirology"},{"key":"3409_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJM199509283331301","volume":"333","author":"L Brochard","year":"1995","unstructured":"Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333:817\u201322.","journal-title":"N Engl J Med"},{"key":"3409_CR34","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2012.87802","volume":"308","author":"G Piaggio","year":"2012","unstructured":"Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA - J Am Med Assoc. 2012;308:2594\u2013604.","journal-title":"JAMA - J Am Med Assoc"},{"key":"3409_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4187\/respcare.06502","volume":"64","author":"F Longhini","year":"2019","unstructured":"Longhini F, Liu L, Pan C, Xie J, Cammarota G, Bruni A, et al. Neurally-adjusted ventilatory assist for noninvasive ventilation via a helmet in subjects with COPD exacerbation: a physiologic study. Respir Care US. 2019;64:582\u20139.","journal-title":"Respir Care US"},{"key":"3409_CR36","first-page":"10863","volume":"12","author":"L Cong","year":"2019","unstructured":"Cong L, Zhou L, Liu H, Wang J. Outcomes of high-flow nasal cannula versus non-invasive positive pressure ventilation for patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Clin Exp Med. 2019;12:10863\u20137.","journal-title":"Int J Clin Exp Med"},{"key":"3409_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S2213-2600(15)00242-8","volume":"3","author":"JL Lopez-Campos","year":"2015","unstructured":"Lopez-Campos JL, Agust\u00ed A. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. Lancet Respir Med Engl. 2015;3:729\u201334.","journal-title":"Lancet Respir Med Engl"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-020-03409-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:20:46Z","timestamp":1607926846000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03409-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3409"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03409-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by \u201cComitato Etico Sezione Area Centro\u201d Ethics Committee (approval no. 245\u2014October 24, 2017, Catanzaro, Italy) and by the local ethics committee of all the study centers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from each participant enrolled or legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Cortegiani, Prof. Giarratano and Prof. Gregoretti declare a patent pending, in association with the University of Palermo\u2014Italy (No. 102019000020532\u2014Italian Ministry of Economic Development), not discussed in the present study. Prof. Gregoretti received honoraria for lectures or consultancies from Philips, Resmed, Vivisol, OrionPharma, Origin (not relevant to this protocol). Prof. Enrico Clini received fees for lectures from Chiesi, Astra-Zeneca, Menarini, Guidotti_Malesci, and AlfaSigma (not relevant to this protocol). Prof. Stefano Nava\u2019s institution received unrestricted research grant from Fisher and Paykel. Prof. Paolo Navalesi\u2019s institution received funding from Maquet Critical Care, Draeger, and Intersurgical S.p.A.; he received honoraria\/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, Merck Sharp & Dome, and Novartis; he disclosed that he contributed to the development of the helmet Next, whose license for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Prof. Federico Longhini and Prof. Paolo Navalesi contributed to the development of a device not discussed in the present study whose patent is in progress (European Patent application number EP20170199831). Dr. Paolo Groff received honoraria for lectures from Aspen Pharmaceuticals and Menarini Pharmaceuticals (not relevant to this study). Dr. Luigi Vetrugno received travel support for congress lecture by Cook Medical. The remaining authors have disclosed that they do not have any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"692"}}